Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer. (11th September 2017)

• Record Type: Journal Article
• Authors: Kassiotis, George; Stoye, Jonathan P.
• Is Part Of: Philosophical transactions. Volume 372:Number 1732(2017)
• Publication Date: 2017-09-11
• Subjects: endogenous retroviruses -- cancer -- immunogenicity; Biology -- Periodicals; Science -- Periodicals; 570
• DOI: 10.1098/rstb.2016.0277
• Languages: English
• ISSNs: 0962-8436

Abstract

Abstract : Like all other mammals, humans harbour an astonishing number of endogenous retroviruses (ERVs), as well as other retroelements, embedded in their genome. These remnants of ancestral germline infection with distinct exogenous retroviruses display various degrees of open reading frame integrity and replication capability. Modern day exogenous retroviruses, as well as the infectious predecessors of ERVs, are demonstrably oncogenic. Further, replication-competent ERVs continue to cause cancers in many other species of mammal. Moreover, human cancers are characterized by transcriptional activation of human endogenous retroviruses (HERVs). These observations conspire to incriminate HERVs as causative agents of human cancer. However, exhaustive investigation of cancer genomes suggests that HERVs have entirely lost the ability for re-infection and thus the potential for insertional mutagenic activity. Although there may be non-insertional mechanisms by which HERVs contribute to cancer development, recent evidence also uncovers potent anti-tumour activities exerted by HERV replication intermediates or protein products. On balance, it appears that HERVs, despite their oncogenic past, now represent potential targets for immune-mediated anti-tumour mechanisms. This article is part of the themed issue 'Human oncogenic viruses'.